Skip to Content Skip to Navigation

ZERO DEATHS
FROM BREAST
CANCER BY 2030

Milestones

Since NBCF’s inception in 1994, there have been remarkable achievements in breast cancer research. Fundraisers and supporters have helped us to raise $173 million towards 538 game-changing research projects in prevention and risk, detection new and improved treatment and quality of life.

Together, with the community’s support, we’ve made an undeniable impact on the face and future of breast cancer in Australia.

But with 8 Australians dying from breast cancer every day, there’s still progress to be made. Join us to make zero deaths from breast cancer by 2030 a reality.

ROAD TO 2030

NBCF is on the road to saving 30,000 more lives to by 2030. Our mission: zero deaths from breast cancer by 2030.

2019 milestone

2019

Research has saved 44, 000 lives to breast cancer since 1994 Survival rates have increased to 91%.

2019

NBCF-funded researcher Professor Patrick Brennan develops training tool for radiologists and breast imaging specialists to improve detection rates across the country.

2019

NBCF-funded researcher Associate Professor Alex Swarbrick develops world-first ‘breast cancer cell atlas’.

2019

NBCF funds unique tumour bank to provide new information on ways to anticipate, inhibit or supress the evolution of drug resistant HER2+ breast cancer.

2018

NBCF funded researcher Professor Kelly-Anne Phillips develops game-changing web-tool iPrevent to help Australian women and their clinicians accurately know and appropriately manage their breast cancer risk.

2017

NBCF introduces innovative 10-year grant funding called Endowed Chair program for emerging leaders in Australian breast cancer research.

2017

Breast cancer becomes the most commonly diagnosed cancer in Australian women.

2017

NBCF joins forces with the Movember Foundation to launch the first-ever Collaborative Breast and Prostate Cancer Linkage Grant to investigate a translational treatment path.

treatment

2016

The 5-year survival rate for breast cancer increases to 90% however incidence is also rapidly on the rise.

2016

NBCF-funded researcher Dr Samantha Oakes identifies that blocking ‘survival protein’ (MCL-1) can decrease cancer metastasis, paving the way for possible future therapies.

EXECUTIVE TEAM

2015

HERG Report found that NBCF-funded research has had a significant impact in key areas such as policy & decision making, development of new drugs and diagnostics, changes in clinical practice and gains in health and quality of life.

2013

NBCF-funded researcher Professor John Simes reveals that taking tamoxifen can reduce the risk of breast cancer recurrence.

2013

NBCF funded researcher Professor Julie Steele developed a world-first Lymph Sleeve (now being patented for commercialisation).

2012

NBCF-funded researcher Dr Brendan Kennedy develops world-first smart surgical glove to ensure that the entire tumour is removed during initial surgery.

NBCF introduces $5 Million Collaborative Grants Scheme to drive national and international research partnerships allowing funding and research outcomes to be better leveraged for more patients across cancer types.

2006

NBCF funds world-first breast cancer tissue bank, to support research by improving knowledge and management of breast cancer in the future.

2004

NBCF releases Australia’s first-ever National Action Plan for breast cancer research and funding, addressing the need to be coordinated at a national level and encourage between researchers, advisors, community members and other key breast cancer organisations

2003

NBCF launched our now-annual Pink Ribbon Breakfast – our biggest community fundraiser event.

2000

NBCF appoints Research Advisory Committee.

1997

NBCF funds the establishment of KConFab, a national and international resource to study familial breast cancer

1994

The National Breast Cancer Foundation is launched.